TRDA·29384C108·US·equity·Healthcare - Biotechnology-Activist
TRDA (ENTRADA THERAPEUTICS INC) is held by 76 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($64M), BlackRock, Inc. ($29.8M), WELLINGTON MANAGEMENT GROUP LLP ($13.1M). Net institutional sentiment: Mixed.
See how TRDA's score breaks down across 4 SEC sources
Showing 1-20 of 82
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer